Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2024
Affiliations
Frauenshuh Cancer Center(Current)
Sue Dasen is an author at Frauenshuh Cancer Center.
Publications per year
2024–2024
Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update.
Marcus Smith Noel, Kurt C. Demel, Bhaskar Srivastava et al. · Journal of Clinical Oncology · 2024 · 10 citations
Rows per page
1–1 of 1